Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Figueras, Albert
and
Capellà, Dolors
1993.
Vol. 17,
Issue. ,
p.
49.
Dassa, Daniel
Kaladjian, Arthur
Azorin, Jean M.
and
Giudicelli, Sebastien
1993.
Clozapine in the Treatment of Psychotic Refractory Depression.
British Journal of Psychiatry,
Vol. 163,
Issue. 6,
p.
822.
Markstein, R.
Urwyler, St.
and
Rüedeberg, C.
1993.
Biologische Psychiatrie der Gegenwart.
p.
13.
Meitzer, Herbert Y.
1993.
New Drugs for the Treatment of Schizophrenia.
Psychiatric Clinics of North America,
Vol. 16,
Issue. 2,
p.
365.
Mulsant, Benoit H.
and
Gershon, Samuel
1993.
Neuroleptics in the treatment of psychosis in late life: A rational approach.
International Journal of Geriatric Psychiatry,
Vol. 8,
Issue. 12,
p.
979.
Eales, M. J.
and
Layeni, A. O.
1994.
Exacerbation of Obsessive–Compulsive Symptoms Associated with Clozapine.
British Journal of Psychiatry,
Vol. 164,
Issue. 5,
p.
687.
Müller-Spahn, F.
and
Kurtz, G.
1994.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
75.
Markstein, R.
1994.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
5.
Gaebel, W.
Klimke, A.
and
Klieser, E.
1994.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
43.
Fuchs, D. Catherine
1994.
Clozapine Treatment of Bipolar Disorder in a Young Adolescent.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 33,
Issue. 9,
p.
1299.
Stevens, I.
and
Gaertner, H. J.
1994.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
59.
Toth, Peter
and
Frankenburg, Frances R.
1994.
Clozapine and Seizures: A Review.
The Canadian Journal of Psychiatry,
Vol. 39,
Issue. 4,
p.
236.
Martínez, J A
Velasco, J J
and
Urbistondo, M D
1994.
Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients..
Journal of the American College of Nutrition,
Vol. 13,
Issue. 2,
p.
192.
MOZES, TAMAR
TOREN, PAZ
CHERNAUZAN, NADEJDA
MESTER, ROBERTO
YORAN-HEGESH, RONI
BLUMENSOHN, RACHEL
and
WEIZMAN, ABRAHAM
1994.
Clozapine Treatment in Very Early Onset Schizophrenia.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 33,
Issue. 1,
p.
65.
Naber, D.
Walther, A.
Kircher, T.
Hayek, D.
and
Holzbach, R.
1994.
Prediction of Neuroleptic Treatment Outcome in Schizophrenia.
p.
85.
Tegeler, J.
1995.
Qualitätssicherung im psychiatrischen Krankenhaus.
p.
109.
Nöthen, M.M.
Rietschel, M.
Erdmann, J.
Oberländer, H.
Möller, H-J.
Naber, D.
Propping, P.
Burnet, PhilipW.J.
and
Harrison, PaulJ.
1995.
Genetic variation of the 5-HT2A receptor and response to clozapine.
The Lancet,
Vol. 346,
Issue. 8979,
p.
908.
Olesen, O. V.
Thomsen, K.
Jensen, P. N.
Rosenberg, R.
Wulff, C. H.
Rasmussen, N. -A.
Refshammer, C.
Bysted, M.
Sørensen, J.
and
Christensen, J.
1995.
Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study.
Psychopharmacology,
Vol. 117,
Issue. 3,
p.
371.
Puri, BK
Taylor, DG
and
Alcock, MEC
1995.
LOW‐DOSE MAINTENANCE CLOZAPINE TREATMENT IN THE PROPHYLAXIS OF BIPOLAR AFFECTIVE DISORDER.
International Journal of Clinical Practice,
Vol. 49,
Issue. 6,
p.
333.
Lacroix, Denis
Chaput, Yves
Rodriguez, Jean-Pierre
Filion, Michel
Morrison, Denis
St-Denis, Pierre
and
Albert, Jean-Marie
1995.
Quantified EEG changes associated with a positive clinical response to clozapine in schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 19,
Issue. 5,
p.
861.
eLetters
No eLetters have been published for this article.